HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of LPS-induced inflammatory biomarkers by ethyl acetate fraction of Patrinia scabiosaefolia through suppression of NF-κB activation in RAW 264.7 cells.

Abstract
Patrinia scabiosaefolia (PS) has been used for curing various types of inflammatory-related disorders. However, the precise mechanism of the anti-inflammatory activity of PS remains unclear. Here, we investigated the anti-inflammatory effects of several fractions isolated from the PS in RAW 264.7 macrophages. The results indicated that the ethyl acetate fraction of PS (EAPS) concentration highly suppressed lipopolysaccharide (LPS)-induced nitric oxide (NO) and IL-6 productions without a cytotoxic effect on RAW 264.7 cells. EAPS inhibited the expressions of LPS-induced iNOS and COX-2 protein and their mRNA in a dose-dependent manner. Particularly, EAPS suppressed the level of nuclear factor-κB (NF-κB) activity, which was linked with the suppression of LPS-induced phosphorylation of p65 at serine 276 and p65 translocation into nuclei, but not MAPK signaling. In addition, treatment with EAPS inhibited the production of TNF-α in LPS-injected mice and suppressed the production of IL-6 and TNF-α in LPS-stimulated splenocytes from BALB/c mice. Therefore, we demonstrate here that Patrinia scabiosaefolia potentially inhibits the biomarkers related to inflammation through the blocking of NF-κB p65 activation, and it may be a potential therapeutic candidate for the treatment of inflammatory diseases.
AuthorsEun-Jung Lee, Chulwon Kim, Jin-Young Kim, Sung-Moo Kim, Dongwoo Nam, Hyeung-Jin Jang, Sung-Hoon Kim, Bum Sang Shim, Kyoo Seok Ahn, Seung-Hoon Choi, Sang Hoon Jung, Kwang Seok Ahn
JournalImmunopharmacology and immunotoxicology (Immunopharmacol Immunotoxicol) Vol. 34 Issue 2 Pg. 282-91 (Apr 2012) ISSN: 1532-2513 [Electronic] England
PMID21854107 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetates
  • Biomarkers
  • Interleukin-6
  • Lipopolysaccharides
  • NF-kappa B
  • Plant Extracts
  • Rela protein, mouse
  • Transcription Factor RelA
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide
  • ethyl acetate
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • Extracellular Signal-Regulated MAP Kinases
  • JNK Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Acetates (chemistry)
  • Animals
  • Biomarkers (blood, metabolism)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Cyclooxygenase 2 (genetics, metabolism)
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Gene Expression (drug effects, genetics)
  • Inflammation (metabolism)
  • Interleukin-6 (metabolism)
  • JNK Mitogen-Activated Protein Kinases (metabolism)
  • Lipopolysaccharides (pharmacology)
  • Lymphocytes (drug effects, metabolism)
  • MAP Kinase Signaling System (drug effects)
  • Macrophages (drug effects, metabolism)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • NF-kappa B (metabolism)
  • Nitric Oxide (metabolism)
  • Nitric Oxide Synthase Type II (genetics, metabolism)
  • Patrinia (chemistry)
  • Phosphorylation (drug effects)
  • Plant Extracts (administration & dosage, isolation & purification, pharmacology)
  • Spleen (cytology)
  • Transcription Factor RelA (metabolism)
  • Tumor Necrosis Factor-alpha (blood, metabolism)
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: